Advertisement

Ads Placeholder
Loading...

ProSomnus, Inc.

OSAPQPNK
Healthcare
Medical - Devices
$0.01
$0.00(2.94%)
U.S. Market opens in 16h 35m

ProSomnus, Inc. Fundamental Analysis

ProSomnus, Inc. (OSAPQ) shows moderate financial fundamentals with a PE ratio of -0.01, profit margin of -87.14%, and ROE of 82.17%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE82.17%
Cash Position2809.55%
PEG Ratio-0.00

Areas of Concern

Operating Margin-69.09%
Current Ratio1.00
We analyze OSAPQ's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -13.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-13.9/100

We analyze OSAPQ's fundamental strength across five key dimensions:

Efficiency Score

Weak

OSAPQ struggles to generate sufficient returns from assets.

ROA > 10%
-91.66%

Valuation Score

Excellent

OSAPQ trades at attractive valuation levels.

PE < 25
-0.01
PEG Ratio < 2
-0.00

Growth Score

Weak

OSAPQ faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

OSAPQ shows balanced financial health with some risks.

Debt/Equity < 1
-1.08
Current Ratio > 1
1.00

Profitability Score

Weak

OSAPQ struggles to sustain strong margins.

ROE > 15%
82.17%
Net Margin ≥ 15%
-87.14%
Positive Free Cash Flow
No

Key Financial Metrics

Is OSAPQ Expensive or Cheap?

P/E Ratio

OSAPQ trades at -0.01 times earnings. This suggests potential undervaluation.

-0.01

PEG Ratio

When adjusting for growth, OSAPQ's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values ProSomnus, Inc. at -0.01 times its book value. This may indicate undervaluation.

-0.01

EV/EBITDA

Enterprise value stands at 3.52 times EBITDA. This is generally considered low.

3.52

How Well Does OSAPQ Make Money?

Net Profit Margin

For every $100 in sales, ProSomnus, Inc. keeps $-87.14 as profit after all expenses.

-87.14%

Operating Margin

Core operations generate -69.09 in profit for every $100 in revenue, before interest and taxes.

-69.09%

ROE

Management delivers $82.17 in profit for every $100 of shareholder equity.

82.17%

ROA

ProSomnus, Inc. generates $-91.66 in profit for every $100 in assets, demonstrating efficient asset deployment.

-91.66%

Following the Money - Real Cash Generation

Operating Cash Flow

ProSomnus, Inc. generates limited operating cash flow of $-17.34M, signaling weaker underlying cash strength.

$-17.34M

Free Cash Flow

ProSomnus, Inc. generates weak or negative free cash flow of $-18.92M, restricting financial flexibility.

$-18.92M

FCF Per Share

Each share generates $-1.09 in free cash annually.

$-1.09

FCF Yield

OSAPQ converts -72.25% of its market value into free cash.

-72.25%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.01

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.01

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.009

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.08

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.00

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.82

vs 25 benchmark

ROA

Return on assets percentage

-0.92

vs 25 benchmark

ROCE

Return on capital employed

-1.60

vs 25 benchmark

How OSAPQ Stacks Against Its Sector Peers

MetricOSAPQ ValueSector AveragePerformance
P/E Ratio-0.0128.77 Better (Cheaper)
ROE82.17%726.00% Weak
Net Margin-87.14%-47290.00% (disorted) Weak
Debt/Equity-1.080.35 Strong (Low Leverage)
Current Ratio1.004.51 Weak Liquidity
ROA-91.66%-17814.00% (disorted) Weak

OSAPQ outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews ProSomnus, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ